Galectin Therapeutics Inc. (GALT) Social Stream



Galectin Therapeutics Inc. (GALT): $1.11

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GALT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 458

in industry

GALECTIN THERAPEUTICS INC (GALT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering GALT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-04-01 1 $14 $14 $14 $1.11 1161.26%
2022-11-15 1 $11 $11 $11 $1.11 890.99%

Price Target Last Issued November 15, 2022

The Trend in the Analyst Price Target


Over the past 22 months, GALT's average price target has gone down $1.

Over the past 33 weeks, GALT's average upside potential has been 673.14%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-01 1 14 14 14 1.58 786.08%
2022-05-17 1 11 11 11 1.35 714.81%
2022-08-16 1 11 11 11 2.18 404.59%
2022-11-15 1 11 11 11 1.24 787.1%

GALT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 52 weeks, GALT's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, GALECTIN THERAPEUTICS INC's number of analysts covering the stock is greater than nearly none of them.
  • In the context of all US stocks, GALECTIN THERAPEUTICS INC's variance in analysts' estimates is lower than almost 100% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, GALECTIN THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 183.79% of them.
  • GALECTIN THERAPEUTICS INC's average analyst price target is higher than 46.44% of Healthcare stocks.

In the Pharmaceutical Products industry, ONTX, LUMO, and CBIO are the three stocks most similar to GALECTIN THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is GALT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6145 seconds.